ARTICLE
The frequency of cutaneous metastases from internal carcinomas ranges
from 0.7 to 10% according to different authors [1-7]. It depends on inclusion
criteria, that is, if melanoma metastases are considered [7] or if data
come from autopsies [1-6] or from clinical records [7]. In women, breast
carcinoma is the internal neoplasm that most frequently leads to skin
metastasis, whereas in men lung carcinoma, carcinoma of large intestine
and carcinoma of the oral cavity are the most common underlying tumours
[7]. The clinical presentation may also be various [7-10]: nodular, inflammatory,
telangiectatic, bullous, cicatricial or "en cuirasse". Inflammatory cutaneous
metastases are frequently observed in patients affected by breast carcinoma
[11, 12]; however this type of metastasis has also been reported in patients
with carcinoma of pancreas [13], rectum [14, 15], lung [16], ovary [17],
parotid gland [18, 19] and urinary bladder [20].
We report a patient with inflammatory skin metastasis from laryngeal
carcinoma.
Case report
S. N., 64-year-old man, a retired cement factory worker, smoker until
5 years before, presented with infiltrated erythematous plaques on his
right supraclavicular and infraclavicular regions (Fig.
1). Skin lesions had irregular margins without clear borders and
a slight swelling was present on his right breast.
Five years before, the patient had undergone a laryngectomy for an epidermoid
carcinoma of the larynx. After surgery he was treated with radiotherapy
using Cobalt 60 for a total dose of 3,000 cGy.
After two years a right laterocervical lymphadenectomy was performed:
12 out of 13 lymph nodes resulted positive for the presence of metastases
from epidermoid carcinoma. Afterwards a further course of radiotherapy
(3,000 cGy) was administrated.
The patient was disease free until two months
before our examination when small erythematous spots appeared on his right
supraclavicular region, slightly enlarging. Two different dermatologists
were consulted and they gave respectively the diagnosis of insect bites
and herpes zoster: however, the treatments they suggested were ineffective.
At admission in our Institute of Dermatology, all the laboratory tests
were normal. A biopsy of skin lesion was taken confirming the diagnosis
of inflammatory cutaneous metastasis from laryngeal epidermoid carcinoma.
Histological examination showed the presence of large cells inside dilated
lymphatic vessels in papillary and reticular dermis (Fig.
2). These cells had eosinophylic cytoplasm with central nucleus
and distinct nucleoli. Atypical cells and mitosis were also observed.
Immunohistochemical markers showed only positive staining of atypical
cells with monoclonal anti-cytokeratin antibodies (cytokeratin B-ORTHO=34betaE12)
(Fig. 3) confirming the
epithelial origin of metastastic cells [21].
Discussion
Inflammatory metastasis generally arises near the primary tumour and
the clinical picture is characterised by marked inflammatory signs like
intense erythema and swelling which can mime an erysipelas; however lack
of fever, shiver and leucocytosis may help to differentiate skin metastasis
from erysipelas. According to these features some authors had defined
it as erysipeloid [20], erysipelatoides [16], or erysipelatodes [12].
This was the word that Rasch used [12], the first author to describe inflammatory
skin metastasis. Inflammatory metastasis is the clinical expression of
rapid spreading of tumour cells along sub-epidermal lymphatic vessels,
which appear in many of them. As a consequence of lymphatic block, oedema,
erythema and vesicles can appear.
Inflammatory cutaneous metastases are frequently observed in patients
with breast carcinoma [11, 12], and their preferential localisation is
on the anterior wall of the thorax. Occasionally it has been observed
during the course of other malignant tumours [13-20]. However, until now,
no inflammatory metastasis from laryngeal epidermoid carcinoma has been
reported in the literature.
Malignant tumour of the larynx generally spreads
to regional lymph nodes or, through blood, to the pulmonary system. Skin
metastasis have rarely been described, always as multiple or solitary
nodules [7, 22, 23]. Another skin lesion frequently observed in patients
after laryngectomy is "stomal recurrence" or "peristomal recurrence" [24-29].
It has been defined as a diffuse infiltrate of neoplastic tissue at the
junction of the amputated trachea and the skin [25]. The lesion usually
presents as a nodule, plaque or exuberant granulation tissue [24-29].
The incidence of stomal recurrences varies from 3.4% [27] to 10% [29]
and it is more frequent in patients who had undergone an "emergency tracheotomy".
However, in our patient, no stomal recurrence had been seen during the
five years follow up after the first surgical operation for laryngeal
carcinoma. Moreover, the erythematous plaques of inflammatory metastasis
were sited on the right upper trunk of the patient and they were not contiguous
to the primary neoplasm or to the stoma of laryngectomy.
Sometimes inflammatory metastasis must be differentiated from lymphangiosarcoma,
arising in swelling regions subjected to radiotherapy (Stewart-Treves'
syndrome). As a matter of fact, our patient had undergone two cycles of
radiotherapy, but immunohistochemical markers showed only positive staining
of atypical cells with monoclonal anti-cytokeratin antibodies (cytokeratin
B-ORTHO=34betaE12) confirming the epithelial origin of metastastic cells.
CONCLUSION In
conclusion we reported this case because of the rarity of cutaneous metastasis
from epidermoid carcinoma of the larynx. Moreover, since such metastasis
normally presents with nodules, we emphasise the particular inflammatory
aspects of skin lesions in this patient. According to our knowledge, it
is the first case of inflammatory cutaneous metastasis from laryngeal epidermoid
carcinoma reported in the literature. REFERENCES
1. McWorther JE, Cloud AW. Malignant tumors and their metastases:
a summary of the necropsies on eight hundred sixty-five cases performed
at the Bellevue Hospital of New York. Ann Surg 1930; 92: 434-43.
2. Gates O. Cutaneous metastases of malignant disease. Am
J Cancer 1937; 30: 718-30.
3. Abrams HL, Siro R, Goldstein N. Metastases in carcinoma: analysis
of 1,000 autopsied cases. Cancer 1950; 3: 74-85.
4. Enticknap JB. An analysis of 1,000 cases of cancer with special
reference to metastasis. Guy's Hosp Rep 1952; 101: 273-9.
5. Reingold IM. Cutaneous metastases from internal carcinoma.
Cancer 1966; 19: 162-8.
6. Spencer PS, Helm TN. Skin metastases in cancer patients. Cutis
1987; 39: 119-21.
7. Lookingbill DP, Spangler N, Helm KF. Cutaneous metastases
in patients with metastatic carcinoma: a retrospective study of 4,020
patients. J Am Acad Dermatol 1993; 29: 228-36.
8. Calvieri S, Chimenti S, Zampetti M, Bottoni U, Nini G, Ribuffo
M. Metastasi cutanee di carcinomi viscerali. Ann It Derm Clin Sper
1980; 34: 349-56.
9. Weber FP. Bilateral thoracic zosterid spreading marginate
teleangiectatic probably a variety of carcinoma and better termed carcinoma
teleangectasicum. Br J Derm 1933; 45: 418-24.
10. Innocenzi D, Bianchi L, Barduagni O, Carlesimo OA. Il carcinoma
telangectasico di Parkes-Weber. Giorn It Derm Vener 1988; 123:
19-24.
11. Tschen EH, Apisarnthanarax P. Inflammatory metastatic carcinoma
of the breast. Arch Dermatol 1981; 117: 120-1.
12. Rasch C. Carcinoma erysipelatodes. Br J Dermatol Syphilol
1931; 43: 351-4.
13. Edelstein JM. Pancreatic carcinoma with unusual metastasis
to the skin and subcutaneous tissue simulating cellulitis. N Engl J
Med 1950; 242: 779-81.
14. Reuter MJ, Nomland R. Inflammatory cutaneous metastatic carcinoma.
Wis Med 1941; 40: 196-201.
15. Kauffman CL, Sina B. Metastatic inflammatory carcinoma of
the rectum: tumor spread by three routes. Am J Dermatopathol 1997;
19: 528-32.
16. Hazelrigg DE, Rudolph AH. Inflammatory metastatic carcinoma.
Arch Dermatol 1977; 113: 69-70.
17. Krishnan EU, Philips AK, Randell A, et al. Bilateral
metastatic inflammatory carcinoma in the breast from primary ovarian cancer.
Obstet Gynecol 1980; 55 (suppl.): 94-6.
18. Schwartz RA, Rubenstein DJ, Raventos A, et al. Inflammatory
metastatic carcinoma of the parotid. Arch Dermatol 1984; 120: 796-7.
19. Aloi F, Colonna SM, Appino A. Metastasi cutanee ad aspetto
infiammatorio da carcinoma parotideo. Giorn It Derm Vener 1987;
122: 193-5.
20. Aloi F, Solaroli C, Paradiso M, Formiconi A. Metastasi cutanee
ad aspetto infiammatorio da tumore vescicale: carcinoma erisipeloide.
Minerva Urol Nefrol 1998; 50: 205-8.
21. Hamakawa H, Sumida T, Bao Y, Tanioka H, Sogawa K, Yamada
T. Species specificity of cytokeratin polypeptide expression in the submandibular
gland. Cell Mol Biol 1999; 45: 265-76.
22. Veraldi S, Cantu A, Sala F, Schianchi R, Gasparini G. Cutaneous
metastases from laryngeal carcinoma. J Dermatol Surg Oncol 1988;
14: 562-4.
23. Horiuchi N, Tagami H. Skin metastasis in laryngeal carcinoma.
Clin Exp Dermatol 1992; 17: 282-3.
24. Batsakis JG, Hybels R, Rice DH. Laryngeal carcinoma: stomal
recurrences and distant metastases. Can J Otolaryngol 1975; 4:
906-16.
25. Griebie MS, Adams GL. "Emergency" laryngectomy and stomal
recurrence. Laryngoscope 1987; 97: 1020-4.
26. Barr GD, Robertson AG, Liu KC. Stomal recurrence: a separate
entity? J Surg Oncol 1990; 44 : 176-9.
27. Rubin J, Johnson JT, Myers EN. Stomal recurrence after laryngectomy:
interrelated risk factor study. Otolaryngol Head Neck Surg 1990;
103: 805-12.
28. Rockley TJ, Powell J, Robin PE, Reid AP. Post-laryngectomy
stomal recurrence: tumour implantation or paratracheal lymphatic metastasis?
Clin Otolaryngol 1991; 16: 43-7.
29. Zbaren P, Greiner R, Kengelbacher M. Stomal recurrence after
laryngectomy: an analysis of risk factors. Otolaryngol Head Neck Surg
1996; 114: 569-75.
|